KMT2A and acute myeloid leukemia: This review aims to provide a comprehensive overview of the molecular characteristics, prognostic implications, and emerging targeted therapies for KMT2A-rearranged AML, highlighting recent advances that lead the way toward precision medicine in this high-risk leukemia subtype.